Activating an invertebrate bistable opsin with the all-trans 6.11 retinal analog.


Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
30 Jul 2024
Historique:
medline: 23 7 2024
pubmed: 23 7 2024
entrez: 23 7 2024
Statut: ppublish

Résumé

Animal vision depends on opsins, a category of G protein-coupled receptor (GPCR) that achieves light sensitivity by covalent attachment to retinal. Typically binding as an inverse agonist, 11-cis retinal photoisomerizes to the all-trans isomer and activates the receptor, initiating downstream signaling cascades. Retinal bound to bistable opsins isomerizes back to the 11-cis state after absorption of a second photon, inactivating the receptor. Bistable opsins are essential for invertebrate vision and nonvisual light perception across the animal kingdom. While crystal structures are available for bistable opsins in the inactive state, it has proven difficult to form homogeneous populations of activated bistable opsins either via illumination or reconstitution with all-trans retinal. Here, we show that a nonnatural retinal analog, all-trans retinal 6.11 (ATR6.11), can be reconstituted with the invertebrate bistable opsin, Jumping Spider Rhodopsin-1 (JSR1). Biochemical activity assays demonstrate that ATR6.11 functions as a JSR1 agonist. ATR6.11 binding also enables complex formation between JSR1 and signaling partners. Our findings demonstrate the utility of retinal analogs for biophysical characterization of bistable opsins, which will deepen our understanding of light perception in animals.

Identifiants

pubmed: 39042699
doi: 10.1073/pnas.2406814121
doi:

Substances chimiques

Retinaldehyde RR725D715M
Opsins 0
Rhodopsin 9009-81-8

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2406814121

Subventions

Organisme : EC | H2020 | PRIORITY 'Excellent science' | H2020 European Research Council (ERC)
ID : 951644
Organisme : EC | H2020 | PRIORITY 'Excellent science' | H2020 European Research Council (ERC)
ID : 701647

Déclaration de conflit d'intérêts

Competing interests statement:The authors declare no competing interest.

Auteurs

Matthew J Rodrigues (MJ)

Laboratory of Biomolecular Research, Department of Biology and Chemistry, Paul Scherrer Institute, Villigen 5232, Switzerland.

Oliver Tejero (O)

Laboratory of Biomolecular Research, Department of Biology and Chemistry, Paul Scherrer Institute, Villigen 5232, Switzerland.
Department of Biology, ETH-Zurich, Zurich, Switzerland.

Jonas Mühle (J)

Laboratory of Biomolecular Research, Department of Biology and Chemistry, Paul Scherrer Institute, Villigen 5232, Switzerland.

Filip Pamula (F)

Laboratory of Biomolecular Research, Department of Biology and Chemistry, Paul Scherrer Institute, Villigen 5232, Switzerland.

Ishita Das (I)

Department of Molecular Chemistry and Materials Science, Weizmann Institute of Science, 76100 Rehovot, Israel.

Ching-Ju Tsai (CJ)

Laboratory of Biomolecular Research, Department of Biology and Chemistry, Paul Scherrer Institute, Villigen 5232, Switzerland.

Akihisa Terakita (A)

Department of Biology, Graduate School of Science, Osaka Metropolitan University, Osaka 558-8585, Japan.
The Osaka Metropolitan University Advanced Research Institute for Natural Science and Technology, Osaka Metropolitan University, Osaka 558-8585, Japan.

Mordechai Sheves (M)

Department of Molecular Chemistry and Materials Science, Weizmann Institute of Science, 76100 Rehovot, Israel.

Gebhard F X Schertler (GFX)

Laboratory of Biomolecular Research, Department of Biology and Chemistry, Paul Scherrer Institute, Villigen 5232, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH